NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

Of course there are ethical transactions that can break the mold. Gilead was an ethical player. For instance, it dared to cure hepatitis C.

That doesn’t change the fact that there are small biotech companies whose market caps are beaten down by unscrupulous players, and then those small biotech companies are bought for cheap.

Your argument that some unscrupulous players would rather buy a company for more because that high purchase cost would eventually enable them to sell their product for more goes in the category of silly.